Denmark: Sound Bioventures announces first close of first fund at €110m

Sound Bioventures, a Scandinavia-based lifesciences venture capital firm, has announced the first close of its first fund at €110m (US$124.3m). Anchor investors are Novo Holdings, Saminvest, Vækstfonden, the European Investment Fund (EIF) and Ramsbury Invest as well as the founders.  The fund will invest in European and US-based private biotech companies and focus on companies…

You must be a HMI Subscriber to view this content.

Subscribe Now »